Tag Archives: leipheimer

After all the hype surrounding the pick-ups made by Omega Pharma-Quick-Step this past off-season, the team’s biggest results this season have so far been earned by riders who were already on the team. But with classics stars such as Tom Boonen and Niki Terpstra staying home to prepare for the Olympics in London, the Belgian … Continue reading →

After months of speculation, it is now confirmed that Levi Leipheimer is joining Patrick Lefevere’s new super-team OmegaPharma-QuickStep. Despite a poor performance at the Tour de France this year, Leipheimer had a solid year with wins at the Tour de Suisse, USA Pro Cycling Challenge in Colorado, the Tour of Utah, and a stage and … Continue reading →

With both the Vuelta and the US Pro Cycling Challenge underway, we take a look at the progress made by riders in these two races: The Vuelta has been heating up, with some technical finishes, late climbs, and a full-blown mountain top finish early in the three-week stage race keeping things interesting. The General Classification … Continue reading →

Interesting cycling items from across the Internet, August 23, 2011 Reports: Leipheimer to Quick Step? UCI awaiting confirmation from Astana team in relation to Vinokourov and Kireyev Cavendish Quits The Vuelta Seen any cool links we missed? Share ’em in the comments below!

Here’s this week’s Monday Musette: 1. The big news from this weekend’s ENECO Tour was Edvald Boasson Hagen’s 22-second defeat of Philippe Gilbert. (It says a lot about Gilbert’s season when he makes more news by losing a race than he does by winning it.) But his victory in today’s Belgian time trial championship … Continue reading →

Pavé would like to thank Handspun, Clément, and Laekhouse for supporting our coverage of the 2011 Tour de France. After yesterday’s crash-marred Stage 5, the peloton is left with a long injury list, including GC contender non-starter Janny Brajkovic, and injuries afflicting stars including Tom Boonen, Alberto Contador, Robert Gesink, Sylvain Chavanel, et al. Were … Continue reading →